Mariel Gailey Kozberg, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Amyloid Angiopathy | 8 | 2024 | 886 | 1.670 |
Why?
|
| Siderosis | 1 | 2023 | 100 | 0.780 |
Why?
|
| Cerebrovascular Circulation | 3 | 2016 | 2674 | 0.520 |
Why?
|
| Hemodynamics | 7 | 2021 | 4184 | 0.510 |
Why?
|
| Afferent Pathways | 1 | 2016 | 303 | 0.480 |
Why?
|
| Cerebral Hemorrhage | 6 | 2024 | 2648 | 0.350 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1870 | 0.260 |
Why?
|
| Stroke | 4 | 2024 | 9747 | 0.250 |
Why?
|
| Brain | 9 | 2024 | 27171 | 0.250 |
Why?
|
| Oxygen | 2 | 2016 | 4241 | 0.240 |
Why?
|
| Nerve Net | 2 | 2016 | 2309 | 0.240 |
Why?
|
| Energy Metabolism | 1 | 2016 | 2892 | 0.240 |
Why?
|
| Brain Mapping | 2 | 2016 | 6601 | 0.230 |
Why?
|
| Amyloid beta-Peptides | 4 | 2024 | 3896 | 0.220 |
Why?
|
| Minocycline | 1 | 2024 | 168 | 0.200 |
Why?
|
| Gliosis | 1 | 2023 | 247 | 0.200 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 5189 | 0.190 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 26 | 0.190 |
Why?
|
| Vertebral Artery | 1 | 2021 | 184 | 0.180 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2021 | 113 | 0.180 |
Why?
|
| American Heart Association | 1 | 2024 | 1047 | 0.170 |
Why?
|
| Cerebral Cortex | 3 | 2021 | 5767 | 0.160 |
Why?
|
| Iron | 2 | 2024 | 1816 | 0.150 |
Why?
|
| Cortical Spreading Depression | 1 | 2021 | 295 | 0.140 |
Why?
|
| Cortical Synchronization | 1 | 2016 | 76 | 0.130 |
Why?
|
| Wakefulness | 1 | 2023 | 1282 | 0.120 |
Why?
|
| Oxyhemoglobins | 1 | 2016 | 213 | 0.120 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2023 | 1022 | 0.120 |
Why?
|
| Physical Stimulation | 1 | 2016 | 513 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 36532 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1087 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2024 | 2643 | 0.110 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 8730 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 839 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2669 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2016 | 1530 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2060 | 0.080 |
Why?
|
| Neurons | 3 | 2021 | 9525 | 0.080 |
Why?
|
| Siloxanes | 1 | 2009 | 27 | 0.080 |
Why?
|
| Animals | 11 | 2024 | 168764 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4752 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9550 | 0.070 |
Why?
|
| Inflammation | 2 | 2024 | 10850 | 0.070 |
Why?
|
| Astrocytes | 2 | 2024 | 1345 | 0.060 |
Why?
|
| Vasodilation | 2 | 2023 | 970 | 0.060 |
Why?
|
| Microglia | 2 | 2024 | 1372 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2009 | 1102 | 0.050 |
Why?
|
| Rats | 3 | 2016 | 23707 | 0.050 |
Why?
|
| Mice | 6 | 2023 | 81819 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22332 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
| Arterioles | 1 | 2023 | 251 | 0.050 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2021 | 30 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 8102 | 0.050 |
Why?
|
| Polymers | 1 | 2009 | 1621 | 0.050 |
Why?
|
| Rose Bengal | 1 | 2021 | 115 | 0.050 |
Why?
|
| Humans | 12 | 2024 | 765968 | 0.040 |
Why?
|
| Risk Management | 1 | 2023 | 559 | 0.040 |
Why?
|
| Age Factors | 1 | 2016 | 18380 | 0.040 |
Why?
|
| Aged | 5 | 2024 | 171117 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8923 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2021 | 594 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2024 | 1470 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 1077 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 603 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2021 | 1262 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 307 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 2060 | 0.020 |
Why?
|
| Female | 5 | 2024 | 396112 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2024 | 41649 | 0.020 |
Why?
|
| Acute Disease | 1 | 2021 | 7232 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10603 | 0.020 |
Why?
|
| Male | 4 | 2024 | 363698 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1930 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2016 | 1747 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 3413 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1499 | 0.020 |
Why?
|
| Thrombosis | 1 | 2021 | 2949 | 0.020 |
Why?
|
| United States | 2 | 2024 | 72903 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5370 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 30260 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 59489 | 0.010 |
Why?
|
| Middle Aged | 2 | 2024 | 223009 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 74840 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40065 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 81514 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65188 | 0.010 |
Why?
|